sulfaphenazole has been researched along with bradykinin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandes, RP; Bredenkötter, D; Busse, R; Dehghani, F; Fisslthaler, B; Fleming, I; Michaelis, UR | 1 |
| Fujiki, T; Hirakawa, Y; Kubota, H; Kunihiro, I; Matoba, T; Morikawa, K; Mukai, Y; Shimokawa, H; Takeshita, A | 1 |
| Akaike, T; Hirakawa, Y; Kubota, H; Kunihiro, I; Matoba, T; Morikawa, K; Mukai, Y; Shimokawa, H; Takeshita, A; Urakami-Harasawa, L | 1 |
| Büssemaker, E; Fauler, J; Fleming, I; Gross, P; Lässig, G; Passauer, J; Pistrosch, F | 1 |
| Bélanger, S; D'Orléans-Juste, P; Gagnon, S; Gendron, G; Gobeil, F; Regoli, D | 1 |
| Cipriano, A; Franzoni, F; Galetta, F; Ghiadoni, L; Magagna, A; Salvetti, A; Taddei, S; Versari, D; Virdis, A | 1 |
| Cocks, T; Selemidis, S | 1 |
| De Negri, F; Duranti, E; Giannarelli, C; Magagna, A; Salvetti, A; Taddei, S; Virdis, A | 1 |
1 trial(s) available for sulfaphenazole and bradykinin
| Article | Year |
|---|---|
Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.
Topics: Adult; Analysis of Variance; Aryl Hydrocarbon Hydroxylases; Bradykinin; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Forearm; Humans; Ibuprofen; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Sulfaphenazole; Vasodilator Agents | 2003 |
7 other study(ies) available for sulfaphenazole and bradykinin
| Article | Year |
|---|---|
Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Animals; Bradykinin; Cell Line; Cells, Cultured; Coronary Vessels; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; DNA, Antisense; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; In Vitro Techniques; NADPH Oxidases; NF-kappa B; Nitric Oxide; Oxygenases; Potassium Chloride; Reactive Oxygen Species; Recombinant Fusion Proteins; Sulfaphenazole; Swine; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vasodilation; Xanthine Oxidase | 2001 |
Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries.
Topics: Aged; Bradykinin; Catalase; Cromakalim; Culture Techniques; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Gap Junctions; Glycyrrhetinic Acid; Humans; Hydrogen Peroxide; Male; Membrane Potentials; Mesenteric Arteries; Middle Aged; Sulfaphenazole; Vasodilation | 2002 |
Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Analysis of Variance; Animals; Biological Factors; Bradykinin; Catalase; Coronary Vessels; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Free Radical Scavengers; Hydrogen Peroxide; Indicators and Reagents; Isotonic Solutions; Male; Microcirculation; Muscle Relaxation; Oxygenases; Polyethylene Glycols; Potassium; Sulfaphenazole; Superoxide Dismutase; Swine | 2003 |
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats.
Topics: Animals; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Humans; Hypotension; Injections, Intravenous; Intracellular Signaling Peptides and Proteins; Male; Peptide Hormones; Phalloidine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Species Specificity; Sulfaphenazole; Time Factors | 2005 |
Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
Topics: Acetylcholine; Adult; Aryl Hydrocarbon Hydroxylases; Ascorbic Acid; Biological Factors; Bradykinin; Case-Control Studies; Cytochrome P-450 CYP2C9; Drug Combinations; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Hypertension; Male; Microcirculation; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Sulfaphenazole; Vasodilation; Vasodilator Agents | 2006 |
Smooth muscle mediates circumferential conduction of hyperpolarization and relaxation to focal endothelial cell activation in large coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apamin; Biological Factors; Bradykinin; Charybdotoxin; Coronary Vessels; Cromakalim; Electrophysiology; Endothelial Cells; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Potassium Channels, Calcium-Activated; Sulfaphenazole; Swine; Thrombin; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Topics: Acetylcholine; Adult; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Bradykinin; Case-Control Studies; Cytochrome P-450 CYP2C9; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Male; Microcirculation; Middle Aged; omega-N-Methylarginine; Sulfaphenazole; Tissue Plasminogen Activator | 2009 |